European Archives - Page 422 of 1107 - European Medical Journal

EMJ 7.4 Feature Image

Tailoring Motor Fluctuation Treatment: Beyond Levodopa Dose Adjustment

Fox emphasised that PD is one of the fastest-growing neurological disorders. Disability and deaths related to it have more than doubled from 1990–2015. Its prevalence is expected to grow exponentially by 2040, affecting approximately 12.9 million individuals worldwide.

The Pathophysiological Relationship Between Migraine and SARS-CoV-2 Infection

People with migraine, and individuals with other neurological conditions, have suffered in multiple aspects during the COVID-19 pandemic. This paper will discuss the factors that impacted the neurology department.

EMJ 7.4 Feature Image

Mexiletine in the Treatment of Non-dystrophic Myotonia: Interviews with Six Medical Experts

NDM includes a group of rare hereditary neuromuscular disorders caused by mutations in the genes that encode sodium or chloride muscle channels.1 Myotonia is the hallmark symptom of NDM and presents as muscle stiffness, often associated with pain, fatigue, and weakness, which can limit function.

EMJ 7.4 Feature Image

Infographic: Differences in Mechanism of Action and Selectivity of Covalent and Non-Covalent BTK Inhibitors

Infographic: Differences in Mechanism of Action and Selectivity of Covalent and Non-Covalent BTK Inhibitors. Provided by Clinical Care Options, LLC. Supported by an educational grant from Lilly.

EMJ 7.4 Feature Image

Adult-Onset Idiopathic Cervical Dystonia

Adult-onset idiopathic focal dystonia is the most common type of primary dystonia, and adult-onset idiopathic cervical dystonia (AOICD) is its most prevalent phenotype.

EMJ 7.4 Feature Image

Infographic: MIUC Treatment Landscape

Infographic: MIUC Treatment Landscape. The publication of this infographic was funded by Bristol Myers Squibb

Amputation Alternatives In Diabetic Foot?

This clinical treatment modality was applied to 62 diabetic ulcers on lower extremities for which surgeons had been advised amputation.

EMJ 7.4 Feature Image

EGFR-Mutant Non-small Cell Lung Cancer: Future Perspectives

This review focuses on the state-of-the-art EGFR-TKIs in the treatment of metastatic NSCLC…

Examining pharma's role in protecting the planet

Pharma is making great strides in tackling climate change, but more needs to be done to meet net zero targets.

Channelling the Myotonia Diagnosis: ICNMD Symposium Presentations

Watch full presentations given by Prof. Dr Kristl Claeys, Dr Guillaume Bassez and Prof. John Vissing at the Lupin-sponsored symposium at the 17th International Congress on Neuromuscular Diseases, in July 2022, in Brussels, Belgium.